Tekmira Pharmaceuticals Corp
SEC CIK 1447028 · TKMR · last insider filing 2026-06-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Beardsley Robert A | Director | filed 2025 - 2026 |
| Sawhney Roger | Director | filed 2025 - 2026 |
| Androski Lindsay | Director · President and CEO | filed 2025 - 2026 |
| Hasija Anuj | Director | filed 2025 - 2025 |
| Gline Matthew | Director | filed 2025 - 2025 |
| Bishop Joseph E | Director | filed 2025 - 2025 |
| Mcelhaugh Michael J. | Director · Interim President & CEO | filed 2018 - 2025 |
| Manchester Keith S | Director | filed 2015 - 2024 |
| Henriques Richard C JR | Director | filed 2014 - 2024 |
| Burgess Daniel D | Director | filed 2017 - 2024 |
| Meyers James R | Director | filed 2018 - 2024 |
| Torti Frank | Director | filed 2018 - 2024 |
| Rewolinski Melissa | Director | filed 2023 - 2024 |
| Collier William H. | Director · President and CEO | filed 2019 - 2023 |
| Tran Tram | Director | filed 2021 - 2022 |
| Cheng Andrew | Director | filed 2019 - 2021 |
| Venker Eric | Director | filed 2020 - 2020 |
| Potter Myrtle S | Director | filed 2018 - 2019 |
| QVT Associates GP LLC | Director | filed 2015 - 2019 |
| QVT Fund V LP | Director | filed 2015 - 2019 |
| Murray Mark J. | Director · President and CEO | filed 2014 - 2019 |
| Conrad Herbert J | Director | filed 2015 - 2018 |
| Ramaswamy Vivek | Director | filed 2015 - 2018 |
| Symonds William T. | Director · Chief Development Officer | filed 2015 - 2018 |
| Karbe Frank | Director | filed 2014 - 2017 |
| Phillips Peggy V | Director | filed 2014 - 2015 |
| Jewell Donald Gordon | Director | filed 2014 - 2015 |
| Kisner Daniel L | Director | filed 2014 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Nguyen Tuan | Chief Financial Officer | filed 2025 - 2026 |
| Hastings David C | Chief Financial Officer | filed 2018 - 2025 |
| Naftzger J. Christopher | General Counsel and CCO | filed 2023 - 2025 |
| Sims Karen | Chief Medical Officer | filed 2023 - 2025 |
| Sofia Michael J. | Chief Scientific Officer | filed 2015 - 2024 |
| Howard Elizabeth | Executive VP & General Counsel | filed 2016 - 2023 |
| Picchio Gaston | Chief Development Officer | filed 2018 - 2022 |
| Vandenenden Koert | Interim CFO | filed 2018 - 2018 |
| Lutwyche Peter | Sr VP, Pharmaceutical Develop | filed 2014 - 2018 |
| Cousins Bruce | Exec VP & CFO | filed 2014 - 2018 |
| Abrams Michael J. | Managing Director | filed 2014 - 2016 |
| Kowalski Mark | Sr VP & Chief Medical Officer | filed 2014 - 2016 |
| Higgins Patrick T. | President & COO | filed 2015 - 2016 |
| Brennan Paul A. | Sr VP, Business Development | filed 2014 - 2015 |
| Gardiner Diane | VP, Human Resources | filed 2014 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.